Substituted 7,8,9,10-tetrahydro-5H-dipyrido1,2-a:3′,2′-epyrazin-6(6aH)-ones

摘要

Disclosed are compounds of the following formula:; in which R₁, R₂, R₅, R₆, R₇, R₁₁, X, and m are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.